Preliminary data from the ESHRE European IVF Monitoring (EIM) Consortium reveals a steady and progressive rise in the use of Assisted Reproductive Technology (ART). In 2022, a total of 960,347 ART treatment cycles were reported by 1,371 clinics across 39 European countries, a 15.6% reduction from the 1,137,177 cycles reported in 2021.

The research revealed widespread disruptions in the activity of genes responsible for early embryonic genome activation, metabolic processes, epigenetic regulation, and chromatin structure in embryos from women with PCOS.

The development of renewable polymers for use in healthcare has shown excellent results, especially in biomedicine, such as in controlled drug release. Using materials like cellulose, chitosan, and starch, scientists have developed advanced ways of applying these polymers to the human body. However, turning these discoveries into commercially available products is still a significant challenge.